3 recruiting, 2 completed, 2 not yet recruiting. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 3 | 2 | Recruiting 2 |
Follow SOFIE: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary 177Lu-FAP-2286 - Cancer of Unknown Primary | Phase 2 | Not yet recruiting | Peter MacCallum Cancer Centre, Australia | 20 | 2026-06-01 | 2026-02-25 |
| 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients 18F-FAPI-74 - Tuberculosis, Pulmonary | Recruiting | Children's Hospital Medical Center, Cincinnati | 30 | 2026-03-12 | 2026-03-31 | |
| Novel Diagnostic and Prognostic Predictors in Fabry Cardiomyopathy: Proof of Concept in a Rare Disease PET scan of 68Ga-FAPI - Fabry Disease | Not yet recruiting | Núcleo de Apoio à Investigação Clínica - FMUP | 20 | 2026-01-01 | 2026-01-20 | |
| Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC) [18F]FAPI-74 PET/CT - Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 3 | Recruiting | SOFIE | 200 | 2025-12-11 | 2026-10-19 |
| Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. [18F]FAPI-74 PET/CT - Esophageal Cancer, Gastric Cancer (GC) | Phase 3 | Recruiting | SOFIE | 200 | 2025-11-14 | 2026-10-19 |
| Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers [18F]FAPI-74 PET/CT - Gastrointestinal Cancers, Cholangiocarcinoma | Phase 2 | Completed | SOFIE | 112 | 2023-04-28 | 2026-10-01 |
| Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma [68Ga]FAPI-46 - PDAC - Pancreatic Ductal Adenocarcinoma, FAP | Phase 2 | Completed | SOFIE | 63 | 2022-05-02 | 2026-05-29 |
Stomach Neoplasms (2) · Carcinoma, Hepatocellular (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Fabry Disease (1) · Gastrointestinal Neoplasms (1) · Tuberculosis, Pulmonary (1)
FAPI-46 (1)
United States (5) · Australia (1)
Sherly Mosessian, Ph.D (2) · Linda Mileshkin (1) · Sanjay Jain, MD (1)
R21AI192087 (1)